EAGLE CRAIG 🟡 adjusted position in 25.2K shares (6 derivative) of Guardant Health, Inc. (GH) at $102.14 ($1.2M) Transaction Date: Jan 01, 2026 | Filing ID: 000002
Chudova Darya 🟡 adjusted position in 23.0K shares (6 derivative) of Guardant Health, Inc. (GH) at $102.14 ($1.3M) Transaction Date: Jan 01, 2026 | Filing ID: 000002
Bell Michael Brian 🟡 adjusted position in 23.0K shares (5 derivative) of Guardant Health, Inc. (GH) at $102.14 ($1.3M) Transaction Date: Jan 01, 2026 | Filing ID: 000002
Director Talasaz AmirAli 🟡 adjusted position in 13.2K shares (2 derivative) of Guardant Health, Inc. (GH) at $102.14 ($1.4M) Transaction Date: Dec 31, 2025 | Filing ID: 000002
Berger Dietmar 🟡 adjusted position in 6.9K shares (1 derivative) of GILEAD SCIENCES, INC. (GILD) at $121.60 Transaction Date: Jan 02, 2026 | Filing ID: 000002
Director Eltoukhy Helmy 🟡 adjusted position in 13.2K shares (2 derivative) of Guardant Health, Inc. (GH) at $102.14 ($1.4M) Transaction Date: Dec 31, 2025 | Filing ID: 000002
ALEXANDER MARGARET A. 🟢 acquired 890.0K shares (1 derivative) of Ovid Therapeutics Inc. (OVID) at $1.76 ($1.6M) Transaction Date: Jan 04, 2026 | Filing ID: 000002
Director Krognes Steve E. 🟡 adjusted position in 0 shares (1 derivative) of Guardant Health, Inc. (GH) Transaction Date: Dec 31, 2025 | Filing ID: 000002
Director YANCOPOULOS GEORGE 🟡 adjusted position in 28.6K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.09 ($22.1M) Transaction Date: Dec 31, 2025 | Filing ID: 000002
Director SCHLEIFER LEONARD S 🟡 adjusted position in 28.6K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.09 ($22.1M) Transaction Date: Dec 31, 2025 | Filing ID: 000002
Director KUEBLER CHRISTOPHER A 🟢 acquired 1.1K shares (1 derivative) of WATERS CORP /DE/ (WAT) at $381.96 Transaction Date: Jan 02, 2026 | Filing ID: 000030